Hyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technol...

The government's latest cancer drug price cuts may offer patients some relief, but the impact could be short-lived. An analysis of medicine...

The Delhi High Court has issued a temporary restraining order against the NPPA's actions toward AstraZeneca Pharma. This order remains in e...

Over the past four quarters, India's medicine sales have increased significantly due to rising demand in chronic care segments. The growth ...

From a pancreatic cancer drug that targets KRAS mutations to a smarter power wheelchair, University of California research is reaching beyo...

Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision...

Nearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...

The Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...

India's pharmaceutical exports increased nearly 5 percent, reaching USD 16.13 billion in the first half of the fiscal year. Growth was driv...

Prices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...

India has capped trade margins at 30% on 137 non-scheduled anti-cancer drugs to reduce treatment costs. Experts call for standardised care,...

Cipla's September-quarter earnings suffered due to a high base in its US business. The company reported sequential growth driven by its str...

Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...

Johnson & Johnson reported results from an early-stage trial of their prostate cancer drug JNJ-6143. The trial involved patients with advan...

Govt has told Supreme Court that hospitals overcharging patients for medicines and medical consumables is a malpractice. Its affidavit cite...

India's National Pharmaceutical Pricing Authority has capped trade margins for 137 anti-cancer drugs at 30% of their maximum retail price. ...

For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...